Login / Signup
Simone Brokamp
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Squamous Cell
Dna Damage
Nk Cells
Prognostic Factors
Top Venues
Cancer discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Paulien Kaptein
,
Nadine Slingerland
,
Christina Metoikidou
,
Felix Prinz
,
Simone Brokamp
,
Mercedes Machuca-Ostos
,
Guido de Roo
,
Ton N M Schumacher
,
Yik A Yeung
,
Kelly D Moynihan
,
Ivana M Djuretic
,
Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool.
Cancer discovery
14 (7) (2024)
Paulien Kaptein
,
Nadine Slingerland
,
Christina Metoikidou
,
Felix Prinz
,
Simone Brokamp
,
Mercedes Machuca-Ostos
,
Guido de Roo
,
Ton N M Schumacher
,
Yik A Yeung
,
Kelly D Moynihan
,
Ivana M Djuretic
,
Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool.
Cancer discovery
14 (7) (2024)
Paulien Kaptein
,
Nadine Slingerland
,
Christina Metoikidou
,
Felix Prinz
,
Simone Brokamp
,
Mercedes Machuca-Ostos
,
Guido de Roo
,
Ton N M Schumacher
,
Yik A Yeung
,
Kelly D Moynihan
,
Ivana M Djuretic
,
Daniela S Thommen
CD8-targeted IL2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool.
Cancer discovery
(2024)
Paulien Kaptein
,
Nadine Slingerland
,
Christina Metoikidou
,
Felix Prinz
,
Simone Brokamp
,
Mercedes Machuca-Ostos
,
Guido de Roo
,
Ton N M Schumacher
,
Yik A Yeung
,
Kelly D Moynihan
,
Ivana M Djuretic
,
Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool.
Cancer discovery
14 (7) (2024)
Paulien Kaptein
,
Nadine Slingerland
,
Christina Metoikidou
,
Felix Prinz
,
Simone Brokamp
,
Mercedes Machuca-Ostos
,
Guido de Roo
,
Ton N M Schumacher
,
Yik A Yeung
,
Kelly D Moynihan
,
Ivana M Djuretic
,
Daniela S Thommen
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool.
Cancer discovery
14 (7) (2024)